EBITDA

With a fresh $72M in financing, Canadian innovator Activate is betting big on its unique blend of physical gaming to build a global entertainment empire.

The new AI TrueCheck system from Pramata promises 99%+ accuracy and full transparency in contract analysis, challenging the opaque nature of legal AI.

As Concentrix sets its Q1 earnings date, investors are watching closely to see if its AI-driven strategy can overcome market headwinds and cautious guidance.

Sarah Sommer, a deaf digital marketing exec, joins the Oberkotter Foundation board, blending personal insight with corporate strategy to advance hearing healthcare.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

Ripple Prime partners with Coinbase and Nodal Clear, offering clients access to regulated crypto derivatives in a major move for institutional adoption.

Scaled Agile's annual summit pivots to AI, unveiling new research on AI's economic reality and a roadmap for enterprises to become truly 'AI-Native'.

A new industry-first model allows health plans to pay only for successful HEDIS gap closures, eliminating financial risk amid rising quality pressures.

With mixed market signals, Gates Industrial's CFO is set to detail the firm's financial strategy and growth outlook at a high-stakes industry event.

As AI adoption outpaces oversight, Check Point’s new advisory service aims to help enterprises manage risk and navigate complex new regulations like the EU AI Act.

The firm's new Google Cloud honors signal a major push in AI-driven government services, promising to reshape how citizens interact with public agencies.

The market data provider's new ISO/IEC 27001:2022 certification signals a new era of trust and resilience in the high-stakes world of financial data.

As AI-generated code introduces new risks, Snyk's partner awards highlight a channel-first strategy to tackle the 'speed paradox' in software security.

A new acquisition in data center alley reveals how investors are profiting from the AI boom by betting on the crucial, but overlooked, support infrastructure.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

A new survey finds AI makes procurement teams 3.7x more resilient, yet many leaders are held back by a dangerous overconfidence in their own knowledge.

With book value soaring, Stack Capital offers a rare public window into the massive valuations of private titans like SpaceX and the AI infrastructure boom.

Iconic Australian bootmaker R.M.Williams expands its partnership with Bamboo Rose, leveraging AI-powered planning to modernize its global operations.

Spirent's new SimXTRACT tool promises to slash PNT development time by bringing real-world satellite signal complexity into the controlled lab environment.

AI drug discovery firm Proxima appoints three titans of science to its board, signaling a major push in proximity therapeutics to rewrite medicine's rules.